Tonix pharmaceuticals holding corp. (TNXP)
Balance Sheet / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Dec'10
ASSETS
Current assets:
Cash and cash equivalents

30,665

11,249

10,024

12,150

16,448

25,034

14,674

16,679

19,253

25,496

29,310

34,355

19,943

18,941

15,644

14,938

8,427

19,175

33,009

48,737

-

38,184

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Restricted cash

-

-

-

-

-

-

99

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Restricted cash

-

-

-

-

-

-

-

89

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Marketable securities-available for sale, at fair value

-

-

-

-

-

-

-

-

-

-

0

0

2,480

7,180

11,094

16,308

-

23,841

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Marketable securities-available for sale, at fair value

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

19,059

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

58,181

-

46,227

43,870

49,547

8,202

7,419

68

423

1,785

35

1,337

2,501

41

0

0

65

Prepaid expenses and other

2,731

2,699

1,529

2,009

2,734

1,022

1,107

1,391

1,429

947

896

1,130

1,009

1,019

2,483

2,414

3,168

3,343

2,142

1,577

1,805

852

699

946

554

429

46

46

67

225

43

-

-

102

-

-

-

Marketable securities - available for sale, at fair value

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

22,038

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

74

64

-

-

-

23

Total current assets

33,396

13,948

11,553

14,159

19,182

26,056

15,880

18,159

20,682

26,443

30,206

35,485

23,432

27,140

29,221

33,660

30,654

46,359

57,189

50,314

59,986

39,036

46,926

44,816

50,101

8,631

7,466

114

491

2,010

78

1,412

2,565

143

-

-

88

Property and equipment, net

28

34

34

36

41

43

55

65

78

91

102

118

132

150

315

349

383

350

327

316

306

328

224

71

43

45

42

38

42

47

51

53

23

25

-

-

32

Right-of-use assets, net

281

356

465

580

579

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Security deposit

7

-

-

13

-

-

-

11

11

11

18

11

11

11

56

56

56

57

56

45

45

45

45

45

-

0

-

-

-

-

-

-

-

-

-

-

3

Deferred financing costs, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

196

-

-

0

Restricted cash

100

100

100

100

100

100

0

0

89

89

89

89

89

89

89

133

133

132

133

133

133

133

133

133

60

60

60

60

60

60

60

60

60

60

-

-

60

Intangible asset

120

120

120

120

120

120

120

120

120

120

120

120

120

120

120

120

120

120

120

120

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred offering costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

100

-

-

-

-

-

-

-

-

-

Total assets

33,932

14,558

12,272

15,008

20,022

26,319

16,055

18,355

20,980

26,754

30,535

35,823

23,784

27,510

29,801

34,318

31,346

47,018

57,825

50,928

60,470

39,542

47,328

45,065

50,204

8,736

7,569

314

594

2,117

190

1,525

2,648

425

0

0

184

LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable

1,408

3,070

1,119

1,044

1,133

1,404

1,051

1,640

1,264

1,296

1,362

1,179

841

872

944

1,935

2,067

3,049

2,422

2,770

1,986

1,487

2,448

1,518

1,399

765

985

1,461

870

825

697

486

182

695

-

-

317

Accrued expenses and other current liabilities

996

1,713

832

562

498

1,251

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Lease liability, current

256

352

415

441

380

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued expenses

-

-

-

-

-

-

1,295

872

1,100

830

475

651

939

1,244

1,676

2,261

1,844

3,601

2,675

1,849

1,531

1,895

1,049

573

596

1,166

853

601

346

310

136

292

98

10

-

-

22

Promissory notes, related party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

280

280

280

280

-

-

0

-

-

-

-

-

-

-

Accrued interest, related party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

200

0

3

3

3

3

38

-

-

0

Liability to placement agent

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

31

-

-

0

Convertible debentures

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

150

-

-

0

Accrued interest, related party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

Total current liabilities

2,660

5,135

2,366

2,047

2,011

2,655

2,346

2,512

2,364

2,126

1,837

1,830

1,780

2,116

2,620

4,196

3,911

6,650

5,097

4,619

3,517

3,382

3,497

2,371

2,275

2,211

2,119

2,262

1,216

1,138

836

782

284

925

-

-

340

Lease liability net of current

25

6

51

139

200

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Warrant liability, including $301,604 to related parties

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,714

-

-

-

-

Convertible debentures, including $265,000 to related parties

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

1,925

-

-

0

Deferred rent payable

-

-

-

-

-

-

0

1

5

12

18

24

29

33

76

88

97

106

77

65

67

68

54

30

6

13

13

15

17

20

27

28

28

29

-

-

19

Accounts Payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

5

3

-

Loan Payable - Related Party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

10

-

-

Loan Payable - Related Party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

10

-

Total liabilities

2,685

5,141

2,417

2,186

2,211

2,655

2,346

2,513

2,369

2,138

1,855

1,854

1,809

2,149

2,696

4,284

4,008

6,756

5,174

4,684

3,584

3,450

3,551

2,401

2,281

2,224

2,133

2,277

1,234

1,158

864

810

3,027

2,879

15

13

359

Commitments (See Note 11)

-

-

-

-

-

-

0

0

-

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

-

-

-

0

0

0

0

0

-

-

0

Stockholders' equity:
Preferred stock, 5,000,000 shares authorized Series B Convertible Preferred stock, $0.001 par value; 5,313 shares designated; 0 issued and outstanding as of March 31, 2020, Series A Convertible Preferred stock, $0.001 par value; 7,938 shares designated; 0 issued and outstanding as of December 31, 2019

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

-

0

-

-

-

Common stock, $0.001 par value; 150,000,000 shares authorized; 49,353,134 and 8,531,504 shares issued and outstanding as of March 31, 2020 and December 31, 2019, respectively, and 1,578 shares to be issued as of December 31, 2019

49

9

2

6

6

-

10

9

8

1

8

7

4

4

29

25

19

2

19

16

16

11

11

10

10

6

4

2

2

2

34

34

34

1

5

-

18

Additional paid in capital

255,601

226,524

218,258

213,380

212,529

212,157

194,592

191,252

187,914

186,990

185,552

185,055

168,283

166,604

160,823

156,171

143,667

142,675

141,653

122,010

120,890

90,423

89,120

80,586

79,804

33,235

28,452

17,965

17,203

16,801

12,506

12,163

7,996

3,939

-

-

2,731

Accumulated deficit

-224,343

-217,070

-208,363

-200,525

-194,685

-188,452

-180,864

-175,385

-169,298

-162,363

-156,870

-151,084

-146,304

-141,240

-133,758

-126,180

-116,374

-102,398

-89,038

-75,788

-64,025

-54,344

-45,355

-37,936

-

-26,728

-

-

-

-

-

-

-

-

-

-

-

Common Stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

5,500.00

-

Additional Paid-in Capital

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

59

59

-

Deficit accumulated during development stage

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

31,892

-

23,021

19,931

17,845

15,844

13,215

11,483

8,409

6,394

-80

-77

2,924

Accumulated other comprehensive loss

-60

-46

-42

-39

-39

-41

-29

-34

-13

-12

-10

-9

-8

-7

11

18

26

-17

17

6

5

2

1

4

1

-1

-

-

-

0

-

-

-

-

-

-

-

Total stockholders' equity

31,247

9,417

9,855

12,822

17,811

23,664

13,709

15,842

18,611

24,616

28,680

33,969

21,975

25,361

27,105

30,034

27,338

40,262

52,651

46,244

56,886

36,092

43,777

42,664

47,923

6,512

5,436

-1,963

-639

959

-674

714

-378

-2,453

-15

-12

-175

Total liabilities and stockholders' equity

33,932

14,558

12,272

15,008

20,022

26,319

16,055

18,355

20,980

26,754

30,535

35,823

23,784

27,510

29,801

34,318

31,346

47,018

57,825

50,928

60,470

39,542

47,328

45,065

50,204

8,736

7,569

314

594

2,117

190

1,525

2,648

425

0

0

184